Positron Emission Tomography And Recovery following Revascularization: Outcomes and Cost-Effectiveness using F-18-fluorodeoxyglucose (FDG) PET in Severe Left Ventricular Dysfunction (PARR Phase 2)

Completed

• Conditions: Coronary artery disease, LV dysfunction, congestive heart failure; Circulatory System; Coronary artery disease

• Registration Number: ISRCTN00827330
• Lead Sponsor: niversity of Ottawa Heart Institute (Canada)

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Study Start: 2007-10-22
• Last Update Posted: 13 January 2015

Recruitment & Eligibility

• Status: Completed
• Sex: All
• Target Recruitment: 430

Inclusion Criteria

1. Age greater than or equal to 18 years, either sex
2. Coronary artery disease documented by coronary angiography, previous myocardial infarction (MI), previous revascularization procedure or positive exercise stress/perfusion imaging
3. Severely reduced LV function with ejection fraction (EF) less than or equal to 35% attributable to coronary disease
4. Any patient being considered for revascularization, transplant/heart failure work up or where in the opinion of the attending physician viability imaging would be considered useful in the ongoing clinical managements

Exclusion Criteria

1. Co-morbid medical conditions likely to make survival for the duration of the study unlikely
2. Less than four weeks post MI
3. Not suitable for revascularization before randomization
4. Patients requiring emergency revascularization
5. Lack of informed consent

Study & Design

• Study Type: Interventional
• Study Design: Not specified